CRELUX is a global leader for structure based drug discovery solutions. Working for pharma, biotech and research organizations our products and services are highly individualized for our customers.
Your discovery projects deserve to receive the best possible support – talk to the experts!
We have been delivering customized and integrated solutions in drug discovery, X-ray crystallography, protein supply, biophysical analysis and fragment screening for more than a decade. Our mission is to enable our clients to perform their work better, faster, more efficiently and more successfully.
CRELUX supports small and large molecule as well as biopharmaceutical drug discovery efforts.
You need individualized answers for your specific challenges. That’s why we invite you to contact us directly so that we can fully understand your needs and develop a tailored solution for you.
Combining our capabilities with the comprehensive portfolio of target to clinical development services offered by our parent company, WuXi AppTec, creates a unique opportunity to accelerate our collaborators discovery activities.
WuXi AppTec is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform company with global operations. As an innovation-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of services to help our worldwide customers and partners shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions.
CRELUX is integrated into WuXi AppTec´s Research Service Division (RSD).